Medulloblastoma in adults
- 16 November 2017
- journal article
- research article
- Published by Springer Nature in Strahlentherapie und Onkologie
- Vol. 194 (3) , 225-234
Abstract
Adult medulloblastoma is a rare disease treated according to the current pediatric treatment guidelines. This retrospective analysis investigated the clinical outcomes and prognostic factors of adult medulloblastoma patients, who received multimodal therapy at our institution.Keywords
This publication has 24 references indexed in Scilit:
- Adjuvant chemotherapy and overall survival in adult medulloblastomaNeuro-Oncology, 2016
- Molecular subgroups of adult medulloblastoma: a long-term single-institution studyNeuro-Oncology, 2016
- Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm studyThe Lancet Oncology, 2016
- Outcomes of adult medulloblastoma treated with a multimodality approach: A tertiary cancer center experienceSouth Asian Journal of Cancer, 2015
- New perspectives in the treatment of adult medulloblastoma in the era of molecular oncologyCritical Reviews in Oncology/Hematology, 2015
- Patterns of care in adult medulloblastoma: results of an international online surveyJournal of Neuro-Oncology, 2014
- Local control in non-metastatic medulloblastomaActa Oncologica, 2014
- Medulloblastoma in adultsStrahlentherapie und Onkologie, 2012
- Adult Medulloblastoma Comprises Three Major Molecular VariantsJournal of Clinical Oncology, 2011
- Long‐term results of a prospective study on the treatment of medulloblastoma in adultsCancer, 2007